🇺🇸 FDA
Patent

US 11203571

Sulfonamides as modulators of sodium channels

granted A61KA61K31/18A61P

Quick answer

US patent 11203571 (Sulfonamides as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/18, A61P, A61P1/00, A61P1/02